Patents by Inventor Timothy J. Deming

Timothy J. Deming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092833
    Abstract: Methodology was developed for transformation of methionine residues into homocysteine derivatives. Methionine residues can undergo alkylation reactions at low pH to yield sulfonium ions, which can then be selectively demethylated to give alkyl homocysteine residues. This process tolerates many functional groups.
    Type: Application
    Filed: August 17, 2023
    Publication date: March 21, 2024
    Inventors: Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20240041742
    Abstract: Provided herein are synthetic copolypeptide hydrogel compositions for use as dermal fillers, and methods of treating dermatological conditions using the same.
    Type: Application
    Filed: December 3, 2021
    Publication date: February 8, 2024
    Inventors: Timothy J. Deming, Michael Delong
  • Patent number: 11732008
    Abstract: Methodology was developed for transformation of methionine residues into homocysteine derivatives. Methionine residues can undergo alkylation reactions at low pH to yield sulfonium ions, which can then be selectively demethylated to give alkyl homocysteine residues. This process tolerates many functional groups.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: August 22, 2023
    Assignee: The Regents of the University of California
    Inventors: Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20220177704
    Abstract: The present disclosure is directed to physical mixtures of diblock copolypeptide hydrogel (DCH) systems. These systems exhibit mechanical strength and stiffness that are synergistically increased over the individual component DCHs, to greater than would be expected for a linear combination of the components. Such systems may have utility in biomedical applications such as drug delivery.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventors: Timothy J. Deming, Yintao Sun
  • Patent number: 11298424
    Abstract: The present invention is directed to copolypeptide hydrogels (DCH) containing non-ionic hydrophilic residues (DCHEO), incorporation of thermoresponsive elements into DCHEO, to generate thermoresponsive DCH (DCHT), and hydrogels that include a combination of DCHEO and DCHT. The invention includes preparation, uses, compositions containing the hydrogels and methods of tuning the hydrogels. The hydrogels can be used to deliver an agent or cells to an organism.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: April 12, 2022
    Assignee: The Regents of the University of California
    Inventors: Timothy J. Deming, Michael V. Sofroniew, Shanshan Zhang
  • Publication number: 20210330795
    Abstract: Disclosed herein are mixtures of triblock or pentablock copolypeptide hydrogels (DCH). These hydrogels possess improved mechanical properties, such as elasticity, that are synergistically increased over the individual component DCHs, to greater than would be expected for a linear combination of the components. Also disclosed herein are methods of making and using the triblock and pentablock copolypeptide hydrogels.
    Type: Application
    Filed: April 23, 2021
    Publication date: October 28, 2021
    Inventors: Timothy J. Deming, Yintao Sun
  • Publication number: 20210206802
    Abstract: A polypeptide comprises amino acids in an amino acid sequence, wherein a portion of the amino acids are covalently linked via a monothioether bridge. In one embodiment, the portion includes amino acids selected from (I) herein n is 0, 1, or 2 and m is 1 or 2. In another embodiments, a hydrogel can include such an amino acid as a crosslinker.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 8, 2021
    Inventors: John McNamara, Nicole G. Ricapito, Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20200288709
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Application
    Filed: October 21, 2019
    Publication date: September 17, 2020
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • Publication number: 20200246503
    Abstract: Described herein are compositions comprising at least two diblock copolypeptides, wherein each copolypeptide has an ionic segment with the opposite charge from the other. The copolypeptides form ?-sheet structured hydrogel assemblies via polyion complexation when mixed in aqueous media. As a result of their unique physical properties, the hydrogels are useful as cell suspension or cell culture media, in drug or cell delivery systems, in scaffolds for tissue repair, or as 3d-printable media.
    Type: Application
    Filed: September 27, 2018
    Publication date: August 6, 2020
    Inventors: Timothy J. Deming, Yintao Sun
  • Patent number: 10448634
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: October 22, 2019
    Assignees: The Regents of the University of California, Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • Patent number: 10351591
    Abstract: Some embodiments of the invention involve methods for introduction of various functional groups onto polypeptides, peptides and proteins by alkylation of thioether (a.k.a. sulfide) groups by ring opening reactions, creating new compositions of matter that may be useful for medical therapeutic or diagnostic applications. The thioether groups may either be present in the polypeptides, or may be added to polypeptides by chemical modification, such as by alkylation of thiol (sulfhydryl) groups.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: July 16, 2019
    Assignee: The Regents of the University of California
    Inventors: Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20190119322
    Abstract: Methodology was developed for transformation of methionine residues into homocysteine derivatives. Methionine residues can undergo alkylation reactions at low pH to yield sulfonium ions, which can then be selectively demethylated to give alkyl homocysteine residues. This process tolerates many functional groups.
    Type: Application
    Filed: April 27, 2017
    Publication date: April 25, 2019
    Applicant: The Regents of the University of California
    Inventors: Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20180105553
    Abstract: Some embodiments of the invention involve methods for introduction of various functional groups onto polypeptides, peptides and proteins by alkylation of thioether (a.k.a. sulfide) groups by ring opening reactions, creating new compositions of matter that may be useful for medical therapeutic or diagnostic applications. The thioether groups may either be present in the polypeptides, or may be added to polypeptides by chemical modification, such as by alkylation of thiol (sulfhydryl) groups.
    Type: Application
    Filed: March 21, 2016
    Publication date: April 19, 2018
    Inventors: Timothy J. Deming, Eric G. Gharakhanian
  • Publication number: 20170296672
    Abstract: The present invention is directed to copolypeptide hydrogels (DCH) containing non-ionic hydrophilic residues (DCHEO), incorporation of thermoresponsive elements into DCHEO, to generate thermoresponsive DCH (DCHT), and hydrogels that include a combination of DCHEO and DCHT. The invention includes preparation, uses, compositions containing the hydrogels and methods of tuning the hydrogels. The hydrogels can be used to deliver an agent or cells to an organism.
    Type: Application
    Filed: October 1, 2015
    Publication date: October 19, 2017
    Applicant: The Regents fo the University of California
    Inventors: Timothy J. Deming, Michael V. Sofroniew, Shanshan Zhang
  • Patent number: 9718921
    Abstract: Methods for preparation of novel amphiphilic derivatives of thioether containing block copolypeptides with narrow chain length distributions are described. These block copolymers can be chemically modified by oxidation and alkylation of the thioether containing residues. These materials generate self-assembled micelles, vesicles and hydrogels, or emulsions with oil phases. These assemblies can be used to encapsulate and delivery therapeutic molecules. The assemblies can be taken up by cells to release molecules from the assemblies.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: August 1, 2017
    Assignee: The Regents of the University of California
    Inventors: Timothy J. Deming, Jessica R. Kramer, April R. Rodriguez
  • Publication number: 20160002405
    Abstract: Methods for preparation of novel amphiphilic derivatives of thioether containing block copolypeptides with narrow chain length distributions are described. These block copolymers can be chemically modified by oxidation and alkylation of the thioether containing residues. These materials generate self-assembled micelles, vesicles and hydrogels, or emulsions with oil phases. These assemblies can be used to encapsulate and delivery therapeutic molecules. The assemblies can be taken up by cells to release molecules from the assemblies.
    Type: Application
    Filed: February 26, 2014
    Publication date: January 7, 2016
    Inventors: Timothy J. Deming, Jessica R. Kramer, April R. Rodriguez
  • Publication number: 20150366193
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Application
    Filed: April 22, 2015
    Publication date: December 24, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • Patent number: 9017730
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: April 28, 2015
    Assignees: The Regents of the University of California, Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • Publication number: 20150057433
    Abstract: Reagents are disclosed for chemoselective tagging of methionine residues in peptides and polypeptides, subsequent bioorthogonal tag functionalization, and cleavage of the tags when desired to regenerate unmodified samples. This method compliments other peptide tagging strategies and adds capability for tag removal, which may be useful for release of therapeutic peptides from a carrier, or release of tagged protein digests from solid supports.
    Type: Application
    Filed: March 26, 2013
    Publication date: February 26, 2015
    Applicant: The Regents of the University of California
    Inventors: Timothy J. Deming, Jessica R. Kramer
  • Publication number: 20140286865
    Abstract: This invention relates, e.g., to a composition suitable for administration to the central nervous system (CNS), comprising a block copolypeptide hydrogel, which comprises a biologically active material that is mixed with the hydrogel or that is attached to the polypeptide chain of the hydrogel, wherein the composition is suitable for administration to the CNS. Also disclosed are methods of making and using compositions of the invention as depots or as scaffolds for cell migration, and pharmaceutical compositions and kits for implementing methods of the invention.
    Type: Application
    Filed: February 18, 2014
    Publication date: September 25, 2014
    Applicant: The Regents of the University of California
    Inventors: Timothy J. Deming, Michael V. Sofroniew, Chu-Ya Yang, BingBing Song, Yan Ao